Biased agonists of the kappa opioid receptor suppress pain and itch without causing sedation or dysphoria | Science Signaling
New Kappa-Opioid Receptor Agonist Curbs Pain, Avoids Side Effects
The mixed kappa and delta opioid receptor agonist, MP1104, attenuates chemotherapy-induced neuropathic pain - ScienceDirect
Biased agonists of the kappa opioid receptor suppress pain and itch without causing sedation or dysphoria | Science Signaling
Targeting the Kappa Opioid Receptor to Reduce Drug Use and Relapse | National Institute on Drug Abuse (NIDA)
Mu Agonist Opioids and Kappa Opioids | Download Table
New Kappa-Opioid Receptor Agonist Curbs Pain, Avoids Side Effects
Mixed Kappa/Mu Partial Opioid Agonists as Potential Treatments for Cocaine Dependence - ScienceDirect
Targeting the Kappa Opioid Receptor to Reduce Drug Use and Relapse | National Institute on Drug Abuse (NIDA)
Behavioral effects of the kappa opioid receptor partial agonist nalmefene in tests relevant to depression - ScienceDirect
The Role of Dynorphin and the Kappa Opioid Receptor in the Symptomatology of Schizophrenia: A Review of the Evidence
New Kappa-Opioid Receptor Agonist Curbs Pain, Avoids Side Effects
Biased agonists of the kappa opioid receptor suppress pain and itch without causing sedation or dysphoria | Science Signaling
Behavioral effects of the kappa opioid receptor partial agonist nalmefene in tests relevant to depression - ScienceDirect
Biased agonists of the kappa opioid receptor suppress pain and itch without causing sedation or dysphoria | Science Signaling
New Kappa-Opioid Receptor Agonist Curbs Pain, Avoids Side Effects
A unique natural selective kappa-opioid receptor agonist, salvinorin A, and its roles in human therapeutics - ScienceDirect
Biased agonists of the kappa opioid receptor suppress pain and itch without causing sedation or dysphoria | Science Signaling
Targeting the Kappa Opioid Receptor to Reduce Drug Use and Relapse | National Institute on Drug Abuse (NIDA)
Biased agonists of the kappa opioid receptor suppress pain and itch without causing sedation or dysphoria | Science Signaling
New Kappa-Opioid Receptor Agonist Curbs Pain, Avoids Side Effects
A Novel Kappa Opioid Receptor Agonist May Unlock New Treatment Strategies for Pain | Pain Research Forum
Behavioral effects of the kappa opioid receptor partial agonist nalmefene in tests relevant to depression - ScienceDirect
Behavioral effects of the kappa opioid receptor partial agonist nalmefene in tests relevant to depression - ScienceDirect
Targeting the Kappa Opioid Receptor to Reduce Drug Use and Relapse | National Institute on Drug Abuse (NIDA)
Targeting the Kappa Opioid Receptor to Reduce Drug Use and Relapse | National Institute on Drug Abuse (NIDA)
Mu Agonist Opioids and Kappa Opioids | Download Table
